SEARCH

SEARCH BY CITATION

References

  • 1
    Gharavi AE, Chu JL, Elkon KB: Autoantibodies to intracellular proteins in human systemic lupus erythematosus are not due to random polyclonal B cell activation. Arthritis Rheum 31: 13371345, 1988
  • 2
    Gleichmann E, van Elven EH, van der Veen JPW: A systemic lupus erythematosus (SLE)-like disease in mice induced by T-B cell cooperation: preferential formation of autoantibodies characteristic of SLE. Eur J Immunol 12: 152159, 1982
  • 3
    Budman DR, Merchant EB, Steinberg AD, Doft B, Gershwin ME, Lizzio E, Reeves JP: Increased spontaneous activity of antibody-forming cells in the peripheral blood of patients with active SLE. Eur J Immunol 15: 11541156, 1985
  • 4
    Theofilopoulos AN, Dixon FJ: Etiopathogenesis of murine systemic lupus erythematosus. Immunol Rev 55: 179216, 1981
  • 5
    Abdou NI, Sagawa A, Pascual E, Herbert J, Sadeghee S: Suppressor T cell abnormality in idiopathic systemic lupus erythematosus. Clin Immunol Immunopathol 6: 192199, 1976
  • 6
    Bresnihan B, Jasin HE: Suppressor function of peripheral blood mononuclear cells in normal individuals and in patients with systemic lupus erythematosus. J Clin Invest 59: 106116, 1977
  • 7
    Fauci AS, Steinberg AD, Haynes BF, Whalen G: Immunoregulatory aberrations in systemic lupus erythematosus. J Immunol 121: 14731978, 1978
  • 8
    Walport M, Ng YC, Lachmann PJ: Erythrocytes transfused into patients with SLE and hemolytic anaemia lose complement receptor type 1 from their cell surface. Clin Exp Immunol 69: 501507, 1987
  • 9
    Frank MM, Hamburger MI, Lawley TJ, Kimberly RP, Plotz PH: Defective reticuloendothelial system Fc-receptor function in systemic lupus erythematosus. N Engl J Med 300: 518523, 1979
  • 10
    Salmon JE, Kimberly RP, Gibofsky A, Fotino M: Defective mononuclear phagocyte function in systemic lupus erythematosus: dissociation of Fc receptor-ligand binding and internalization. J Immunol 133: 25252431, 1984
  • 11
    Liszewski MK, Kahl LE, Atkinson JP: The functional role of complement genes in systemic lupus erythematosus and Sjögrens syndrome. Curr Opin Rheumatol 1: 347352, 1989
  • 12
    Lie JT: Vasculopathy in the antiphospholipid syndrome: thrombosis or vasculitis, or both? J Rheumatol 16: 713715, 1989
  • 13
    Lie JT: Vasculitis in the antiphospholipid syndrome: culprit or consort? J Rheumatol 21: 397399, 1994
  • 14
    Lie JT, Kobayashi S, Tokano Y, Hashimoto H: Systemic and cerebral necrotizing vasculitis coexisting with disseminated coagulopathy in systemic lupus erythematosus associated with antiphospholipid syndrome. J Rheumatol (in press)
  • 15
    Baehr G, Klemperer P, Schifrin A: A diffuse disease of the peripheral circulation (usually associated with lupus erythematosus and endocarditis). Trans Assoc Am Physicians 50: 139155, 1935
  • 16
    Klemperer P, Pollack AD, Baehr G: Pathology of disseminated lupus erythematosus. Arch Pathol 32: 569631, 1941
  • 17
    Baldwin DS, Gluck MC, Lowenstein J, Gallo GR: Lupus nephritis: clinical course as related to morphological forms and their transition. Am J Med 62: 1230, 1977
  • 18
    Bhathena DB, Sobel BJ, Migdal SD: Noninflammatory renal microangiopathy of systemic lupus erythematosus (lupus vasculitis). Am J Nephrol 1: 144159, 1981
  • 19
    Bhuyan UN, Malaviya AN, Dash SC, Malhotra KK: Prognostic significance of renal angiitis in systemic lupus erythematosus (SLE). Clin Nephrol 20: 109113, 1983
  • 20
    Tsumagari T, Fukumato S, Kinjo M, Tanaka K: Incidence and significance of intrarenal vasculopathies in patients with systemic lupus erythematosus. Hum Pathol 16: 4349, 1985
  • 21
    Grishman E, Venkatasehan VS: Vascular lesions in lupus nephritis. Mod Pathol 1: 235241, 1988
  • 22
    Doherty NE, Siegel RJ: Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110: 12571265, 1985
  • 23
    Mandell BF: Cardiovascular involvement in systemic lupus erythematosus. Semin Arthritis Rheum 17: 126141, 1987
  • 24
    Sturfelt G, Eskilsson J, Nived O, Truedsson L, Valina S: Cardiovascular disease in systemic lupus erythematosus. Medicine (Baltimore) 71: 216223, 1992
  • 25
    Schwab EP, Schumacher HR, Freundlich B, Calligari PE: Pulmonary alveolar hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 23: 815, 1993
  • 26
    Lie JT: Rheumatic connective tissue disease. In, Pulmonary Pathology. Second edition. Edited by DHDail, SPHammar. New York, Springer-Verlag, 1994
  • 27
    Kistin MG, Kaplan MM, Harrington JT: Diffuse ischemic colitis associated with systemic lupus erythematosus: response to subtotal colectomy. Gastroenterology 75: 11471151, 1978
  • 28
    Zizic TM, Classen JN, Stevens MB: Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. Am J Med 73: 525531, 1982
  • 29
    Helliwell TR, Flook D, Whitworth J, Day DW: Arteritis and venulitis in systemic lupus erythematosus resulting in massive lower intestinal hemorrhage. Histopathology 9: 11031113, 1985
  • 30
    Laing TJ: Gastrointestinal vasculitis and pneumatosis intestinalis due to systemic lupus erythematosus: successful treatment with pulse intravenous cyclophosphamide. Am J Med 85: 555558, 1988
  • 31
    Winkelmann RK, Schroeder AL, Kierland RR, Ryan TM: Clinical studies of lividoid vasculitis (segmental hyalinizing vasculitis). Mayo Clin Proc 49: 746750, 1974
  • 32
    Gilliam JN, Smiley JD: Cutaneous necrotizing vasculitis and related disorders. Ann Allergy 37: 328339, 1976
  • 33
    Marin OSM, Estanol BV: Cerebral vasculitis presenting as a meningoencephalitis: a case of systemic lupus erythematosus. Delaware Med J 45: 315319, 1973
  • 34
    Ellis SG, Verity MA: Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955–1977. Semin Arthritis Rheum 8: 212221, 1979
  • 35
    Abramowsky CR, Vegas ME, Swinehart G, Gyves MT: Decidual vasculopathy of placenta in lupus erythematosus. N Engl J Med 303: 668672, 1980
  • 36
    Suzuki Y, Kitagawa Y, Matsuoka Y, Fukuda J, Mizushima Y: Severe cerebral and systemic necrotizing vasculitis developing during pregnancy in a case of systemic lupus erythematosus. J Rheumatol 17: 14081411, 1990
  • 37
    Lie JT: Takayasu's arteritis. In, Systemic Vasculitides. Edited by AChurg, JChurg. New York, Igaku-Shoin, 1991
  • 38
    Igarashi T, Nagaoka S, Matsunaga K, Katoh K, Ishigatsiho Y, Tani K, Lie JT: Aortitis syndrome (Takayasu's arteritis) associated with systemic lupus erythematosus. J Rheumatol 16: 15791583, 1989
  • 39
    Saxe PA, Altman RD, Igarashi T, Tani K, Lie JT: Aortitis syndrome (Takayasu's arteritis) associated with SLE. J Rheumatol 17: 12511252, 1990
  • 40
    Saxe PA, Altman RD: Takayasu's arteritis syndrome associated with systemic lupus erythematosus. Semin Arthritis Rheum 21: 295305, 1992
  • 41
    Lorber M, Gershwin ME, Shoenfeld Y: The coexistence of systemic lupus erythematosus with other autoimmune diseases: the kaleidoscope of autoimmunity. Semin Arthritis Rheum 24: 105113, 1994
  • 42
    Mintz G, Galindo L, Fernandez-Diez J, Jimenez FJ, Robles-Saavedra E, Enriquez-Casillas R: Acute massive pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 5: 3950, 1978
  • 43
    Eagen JW, Memoli V, Roberts J, Matthew GR, Schwartz MM, Lewis EJ: Pulmonary hemorrhage in systemic lupus erythematosus. Medicine (Baltimore) 57: 545560, 1978
  • 44
    Leatherman JW, Davies S, Hoidal J: Alveolar hemorrhage syndrome: diffuse microvascular lung hemorrhage in immune and idiopathic disorders. Medicine (Baltimore) 63: 343361, 1984
  • 45
    Abud-Mendoza C, Diaz-Jananen E, Alarcón-Segovia D: Fatal pulmonary hemorrhage in systemic lupus erythematosus. J Rheumatol 2: 558561, 1985
  • 46
    Onomura K, Nakata H, Tanaka Y, Tsuda T: Pulmonary hemorrhage in patients with systemic lupus erythematosus. J Thorac Imag 6: 5761, 1991
  • 47
    Rodriguez-Iturbe B, Garcia R, Rubio L, Cuenca L: Immunohistologic findings in the lung in systemic lupus erythematosus. Arch Pathol Lab Med 101: 342344, 1977
  • 48
    Eagen JW, Roberts J, Schwartz M, Lewis EJ: The composition of pulmonary immune deposits in systemic lupus erythematosus. Clin Immunol Immunopathol 12: 204219, 1978
  • 49
    Myers JL, Katzenstein AL: Microangiitis in lupus induced pulmonary hemorrhage. Am J Clin Pathol 85: 552556, 1986
  • 50
    Pines A, Kaplinsky N, Olchovsky D, Rozenman J, Frankl O: Pleuropulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups, prognostic and therapeutic implications. Chest 88: 129135, 1985
  • 51
    Miller LR, Greenberg S, McLarty J: Lupus lung. Chest 88: 265269, 1985
  • 52
    Segal AM, Calabrese L, Ahmad M, Tubbs R, White CS: The pulmonary manifestations of systemic lupus erythematosus. Semin Arthritis Rheum 14: 202224, 1985
  • 53
    Erickson RW, Franklin WA, Emlen W: Treatment of hemorrhagic lupus pneumonitis with plasmapheresis. Semin Arthritis Rheum 24: 114123, 1994
  • 54
    Hill GS: Systemic lupus erythematosus and mixed connective tissue disease. In, Pathology of the Kidney. Fourth edition. Edited by RHHeptinstall. Boston, Little, Brown and Company, 1992
  • 55
    Katz SM, Kern S, Umlas SL, DeHoratius RJ: Renal vascular lesions in systemic lupus erythematosus. Ann Clin Lab Sci 20: 147153, 1990
  • 56
    Nesher G, Hanna VE, Moore TL, Hersh M, Osborn TG: Thrombic microangiopathic hemolytic anemia in systemic lupus erythematosus. Semin Arthritis Rheum 24: 165172, 1994
  • 57
    Jain R, Chartash E, Susin M, Furie R: Systemic lupus erythematosus complicated by thrombotic microangiopathy. Semin Arthritis Rheum 24: 173182, 1994
  • 58
    Koeffler P, Schur P, Kunkel H: Immunological studies concerning the nephritis of systemic lupus erythematosus. J Exp Med 126: 607624, 1967
  • 59
    Fauci TY, Haynes BF, Katz P: The spectrum of vasculitis. Ann Intern Med 89: 660676, 1978
  • 60
    Arthus M: Injections repetees de serum de cheval chez la lapin. Soc Biol 1903
  • 61
    Ishizaka K: Gamma globulin and molecular mechanisms in hypersensitivity reactions. Prog Allergy 7: 3240, 1963
  • 62
    Frank MM, Ellman L, Green I, Cochrane C: Site of deposition of C3 in Arthus reactions of C4 deficient guinea pigs. J Immunol 110: 14471451, 1973
  • 63
    Lawley TJ, Frank MM: Immune complexes and immune complex diseases. In, Clinical Immunology. Edited by CWParker. Philadelphia, WB Saunders, 1980
  • 64
    Cochrane CG: The Arthus reaction. In, The Inflammatory Process. Edited by BWZweifach, LGrant, RTMcCluskey. New York, Academic Press, 1965
  • 65
    Sylvestre DL, Ravetch JV: Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. Science 265: 10951098, 1994
  • 66
    Dixon FJ, Feldman JD, Vazquez JJ: Experimental glomerulonephritis: the pathogenesis of a laboratory model resembling the spectrum of human glomerulonephritis. J Exp Med 113: 899920, 1961
  • 67
    Cochrane CG, Koffler D: Immune complex disease in experimental animals and man. In, Advances in Immunology. Edited by FJDixon, HGKunkel. New York, Academic Press, 1973
  • 68
    Belmont HM, Hopkins P, Edelson HS, Kaplan HB, Ludewig R, Weissmann G, Abramson S: Complement activation during systemic lupus erythematosus: C3a and C5a anaphylatoxins circulate during exacerbations of disease. Arthritis Rheum 29: 10851089, 1986
  • 69
    Hopkins P, Belmont M, Buyon J, Philips MR, Weissmann G, Abramson SB: Increased plasma anaphylotoxins in systemic lupus erythematosus predict flares of the disease and may elicit the adult cerebral distress syndrome. Arthritis Rheum 31: 632641, 1988
  • 70
    Belmont HM, Buyon J, Giorno R, Abramson S: Up-regulation of endothelial cell adhesion molecules characterizes disease activity in systemic lupus erythematosus: the Shwartzman phenomenon revisited. Arthritis Rheum 37: 376383, 1994
  • 71
    Jacob HS, Craddock PR, Hammerschmidt DE, Moldow CF: Complement-induced granulocyte aggregation: an unsuspected mechanism of disease. N Engl J Med 302: 789794, 1980
  • 72
    Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS: Association of complement activation and elevated plasma-C5a with adult respiratory distress syndrome. Lancet 1: 947949, 1980
  • 73
    Hakim R, Breillatt J, Lazarus M, Prt K: Complement activation and hypersensitivity reactions to hemodialysis membranes. N Engl J Med 311: 878882, 1984
  • 74
    Craddock P, Fehr J, Dalmasso A, Brigham K, Jacob H: Hemodialysis leukopenia. J Clin Invest 59: 879888, 1977
  • 75
    Chenoweth DE, Cooper SW, Hugli TE, Stewart RW, Balckstone EH, Kirklin SW: Complement activation during cardiopulmonary bypass. N Engl J Med 304: 497505, 1981
  • 76
    Perez HD, Horn JK, Ong R, Goldstein I: Complement (C5)-derived chemotactic activity in serum from patients with pancreatitis. J Lab Clin Med 101: 123129, 1983
  • 77
    Shwartzman G: Phenomenon of Local Tissue Reactivity. New York, Paul Hoeber, 1937
  • 78
    Argenbright L, Barton R: Interactions of leukocyte integrins with intercellular adhesion molecule 1 in the production of inflammatory vascular injury in vivo: the Shwartzman phenomenon revisited. J Clin Invest 89: 259273, 1992
  • 79
    Abramson SB, Weissmann G: Complement split products and the pathogenesis of SLE. Hosp Prac 23: 4555, 1988
  • 80
    Pohlman TM, Stanness KA, Beatty PG, Ochs HD, Harlan JM: An endothelial cell surface factor induced in vitro by lipopolysaccharide, interleukin-1, and tumor necrosis factor increased neutrophil adherence by a CDw18 dependent mechanism. J Immunol 136: 45484553, 1986
  • 81
    Pober JS, Gimbrone M, Lapierre D, Mendrick L, Fiers W, Rothlein R, Springer T: Overlapping patterns of activation of human endothelial cells by interleukin-1, tumor necrosis factor and immune interferon. J Immunol 137: 18931896, 1986
  • 82
    Fletcher MP, Seligmann BE, Gallin JI: Correlation of human neutrophil secretion, chemoattractant receptor mobilization and enhanced functional capacity. J Immunol 128: 941948, 1982
  • 83
    Buyon J, Tamerius J, Belmont HM, Abramson S: Assessment of disease activity and impending flare in patients with systemic lupus erythematosus: comparison of the use of complement split products and conventional measurements of complement. Arthritis Rheum 35: 10281037, 1992
  • 84
    Schur PH, Sandson J: Immunologic factors and clinical activity in systemic lupus erythematosus. N Engl J Med 278: 533538, 1968
  • 85
    Buyon JP, Shadick N, Berkman R, Hopkins P, Dalton J, Weissmann G, Winchester R, Abramson SB: Surface expression of gp 165/95, the complement receptor CR3, as a marker of disease activity in systemic lupus erythematosus. Clin Immunol Immunopathol 46: 141149, 1988
  • 86
    Philips MR, Abramson SB, Weissmann G: Neutrophil adhesion and autoimmune vascular injury. Clin Aspects Autoimmun 3: 315, 1989
  • 87
    Johnson RT, Richardson EP: The neurological manifestations of systemic lupus erythematosus: a clinical pathological study of 24 cases and a review of the literature. Medicine (Baltimore) 47: 337369, 1968
  • 88
    Hanley JG, Walsh NMG, Sangalang V: Brain pathology in systemic lupus erythematosus. J Rheumatol 19: 732741, 1992
  • 89
    Hammad A, Tsukada Y, Torre N: Cerebral occlusive vasculopathy in systemic lupus erythematosus and speculation on the part played by complement. Ann Rheum Dis 51: 550552, 1992
  • 90
    Devinsky O, Petito CK, Alonso DR: Clinical and neuropathological findings in systemic lupus erythematosus: the role of vasculitis heart emboli and thrombotic thrombocytopenic purpura. Ann Neurol 23: 380384, 1988
  • 91
    Abramson SB, Dobro J, Eberle MA, Benton M, Reibman J, Epstein H, Belmont HM, Rapoport DM, Goldring RM: The syndrome of acute reversible hypoxemia of systemic lupus erythematosus. Ann Intern Med 114: 941947, 1991
  • 92
    Bone RC: Why new definitions of sepsis and organ failure are needed. Am J Med 95: 348350, 1993
  • 93
    Nogare D: Septic shock. Am J Med Sci 302: 5065, 1991
  • 94
    Waage A, Brandtzaeg P, Espevik T, Halstensen A: Current understanding of the pathogenesis of gram-negative shock. Infect Dis Clin North Am 5: 781789, 1991
  • 95
    Walsh CJ, Carey PD, Bechard DE, Fowler AA, Sugerman HJ: Anti-CD 18 antibody attenuates neutropenia and alveolar capillary-membrane injury during gram-negative sepsis. Surgery 110: 205211, 1991
  • 96
    Macworth-Young CG, Loizou S, Walport MJ: Antiphospholipid antibodies and disease. Q J Med 72: 767777, 1989
  • 97
    McNeil HP, Chesterman CN, Krilis SA: Immunology and clinical importance of antiphospholipid antibodies. Adv Immunol 49: 193280, 1991
  • 98
    Hughes GRV: The antiphospholipid syndrome: ten years on. Lancet 342: 341344, 1993
  • 99
    Tanaka M, Kobayashi S, Tamura N, Hashimoto H, Hirose SI: Disseminated intravascular coagulation in a patient with systemic lupus erythematosus with lupus anticoagulant. Intern Med 32: 513517, 1993
  • 100
    Cervera R, Asherson RA, Lie JT: Clinicopathologic correlations in antiphospholipid syndromes. Semin Arthritis Rheum 24: 262272, 1995
  • 101
    Lie JT: Pathology of antiphospholipid syndromes. In, The Antiphospholipid Syndrome. Edited by RAAsherson, RCervera, JCPiette, YSchoenfeld. Boca Raton, FL, CRC Press (in press)
  • 102
    Zelger B, Sepp N, Schmid KW, Hintner H, Klein G, Fritsch PO: Life history of cutaneous vascular lesions in Sneddon's syndrome. Hum Pathol 23: 668567, 1992
  • 103
    Hughson MD, McCarty GA, Sholer CM, Brumback RA: Thrombotic cerebral arteriopathy in patients with the antiphospholipid syndrome. Mod Pathol 6: 644653, 1993
  • 104
    D'Cruz D, Hughes G: Antibodies, thrombosis and the endothelium. Br J Rheumatol 33: 24, 1994
  • 105
    Yoshio T, Masuyama JI, Sumiya M, Minota S, Kano S: Antiendothelial cell antibodies and their relation to pulmonary hypertension in systemic lupus erythematosus. J Rheumatol 21: 20582063, 1994
  • 106
    Harris EN, Gharavi AE, Hughes GRV: Antiphospholipid antibodies. Clin Rheum Dis 11: 591609, 1985
  • 107
    Harris EN, Chan JKH, Asherson RA, Aber VR, Gharavi AE, Hughes GRV: Thrombosis, recurrent fetal loss and thrombocytopenia: predictive value of the anticardiolipin antibody test. Arch Intern Med 146: 21532156, 1986
  • 108
    Asherson RA: The catastrophic antiphospholipid syndrome. J Rheumatol 19: 508512, 1992
  • 109
    Pérez RE, McClendon JR, Lie JT: Primary antiphospholipid syndrome with multiorgan arterial and venous thrombosis. J Rheumatol 19: 12891292, 1992
  • 110
    Mackworth-Young CG, David J, Louizou S, Walport MJ: “Primary” antiphospholipid syndrome: features of patients with raised anticardiolipin antibodies and no other disorders. Ann Rheum 48: 362367, 1989
  • 111
    Asherson RA, Khamashta MA, Ordi-Ros J, Derken RHW, Machin SJ, Barquinero J, Outt HH, Harris EN, Vilardell-Thorres M, Hughes GRV: The “primary” antiphospholipid syndrome: major clinical and serologic features. Medicine (Baltimore) 68: 366374, 1989
  • 112
    Vianna JL, Khamashta MA, Ordi-Rios J, Font J, Cervera R, Lopez-Soto A, Tolosa C, Fraz J, Selva A, Ingelmo M, Vilardell M, Hughes GRV: Comparison of the primary and secondary antiphospholipid syndrome: a European multicenter study of 114 patients. Am J Med 96: 39, 1994
  • 113
    Kant KS, Pollak VE, Weiss MA, Glueck HI, Miller MA, Hess EV: Glomerular thrombosis in systemic lupus erythematosus: prevalence and significance. Medicine (Baltimore) 60: 7187, 1981
  • 114
    Hughson MD, Nadasdy T, McCarty GA, Sholer C, Min KW, Silva F: Renal thrombotic microangiopathy in patients with systemic lupus erythematosus and the antiphospholipid syndrome. Am J Kidney Dis 20: 150158, 1992
  • 115
    Harris EN, Gharavi AE, Asherson RA, Boey MA, Hughes GRV: Cerebral infarction in systemic lupus: association with anticardiolipin antibodies. Clin Exp Rheumatol 2: 4751, 1984
  • 116
    Derkson RHWM, Bouma BN, Kater L: The association between the lupus anticoagulant and cerebral infarction in systemic lupus erythematosus. Scand J Rheumatol 15: 179184, 1986
  • 117
    The Antiphospholipid Antibodies in Stroke Study Group: Clinical and laboratory findings in patients with antiphospholipid antibodies and cerebral ischemia. Stroke 21: 12681273, 1990
  • 118
    Asherson RA, Ridley M, Fletcher CDM, Hughes GRV: Systemic lupus erythematosus, pulmonary hypertension and adult respiratory distress syndrome. Clin Exp Rheumatol 6: 301304, 1988
  • 119
    Andonopoulos AP: Adult respiratory distress syndrome: an unrecognized postmortem event in systemic lupus erythematosus. Br J Rheumatol 30: 346348, 1991
  • 120
    Hillerdal G, Hagg A, Licke G, Wegenius G, Scheibenpflug L: Intraalveolar haemorrhage in the anticardiolipin antibody syndrome. Scand J Rheumatol 20: 5862, 1991
  • 121
    Gertner E, Lie JT: Pulmonary capillaritis, alveolar hemorrhage, and recurrent microvascular thrombosis in primary antiphospholipid syndrome. J Rheumatol 20: 12241228, 1993
  • 122
    Alegre VA, Gastineau DA, Winkelmann RK: Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 120: 419429, 1989
  • 123
    Grob JJ, Bonerandi JJ: Thrombotic skin disease as a marker of the anticardiolipin syndrome: livido vasculitis and distal gangrene associated with abnormal serum antiphospholipid activity. J Am Acad Dermatol 20: 10631069, 1989
  • 124
    McCalmont CS, McCalmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H: Livido vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol 17: 48, 1992
  • 125
    Gertner E, Lie JT: Systemic therapy with fibrinolytic therapy and heparin for recalcitrant nonhealing cutaneous ulcer in the antiphospholipid syndrome. J Rheumatol 21: 21592161, 1994
  • 126
    Hughes GR, Khamashta MA: The antiphospholipid syndrome. J R Coll Physicians Lond 28: 301304, 1994
  • 127
    Ordi-Ros J, Perez-Peman P, Monasterio J: Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies). Haemostasis 24: 165174, 1994
  • 128
    Bevers EM, Galli M: Cofactors involved in the antiphospholipid syndrome. Lupus 1: 5153, 1992
  • 129
    Ozawa N, Makino T, Matsubayashi H, Hosokawa, Someya K, Nozawa S, Matsuura E: Beta 2-GPI-dependent and independent binding of anticardiolipin antibodies in patients with recurrent spontaneous abortions. J Clin Lab Anal 8: 255259, 1994
  • 130
    Aron AL, Gharavi AE, Shoenfeld Y: Mechanisms of action of antiphospholipid antibodies in the antiphospholipid syndrome. Int Arch Allergy Immunol 106: 812, 1995
  • 131
    Pierangeli SS, Harris EN: Antiphospholipid antibodies in an in vivo thrombosis model in mice. Lupus 3: 247251, 1994
  • 132
    Triplett DA: Antiphospholipid antibodies: proposed mechanisms of action. Am J Reprod Immunol 28: 211215, 1992
  • 133
    Wiener HM, Vardinon N, Yust I: Platelet antibody binding and spontaneous aggregation in 21 lupus anticoagulant patients. Vox Sanguinis 61: 111121, 1991
  • 134
    Vazquez-Mellado J, Llorente L, Richaud-Patin Y, Alarcón-Segovia D: Exposure of anionic phospholipids upon platelet activation permits binding of beta 2 glycoprotein I and through it that of IgG antiphospholipid antibodies: studies in platelets from patients with antiphospholipid syndrome and normal subjects. J Autoimmun 7: 335348, 1994
  • 135
    Lindsey NJ, Hendeson FI, Malia R, Milford-Ward MA, Greaves M, Hughes P: Inhibition of prostacyclin release by endothelial binding anticardiolipin antibodies in thrombosisprone patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 33: 2026, 1994
  • 136
    Westerman EM, Miles JM, Backonja M, Sundstrom WR: Neuropathologic findings in multi-infarct dementia associated with anticardiolipin antibody: evidence for endothelial injury as the primary event. Arthritis Rheum 35: 10381041, 1992
  • 137
    McCraw KR, DeMichele A, Samuels P, Roth D, Kuo A, Meng QH, Rauch J, Cines DB: Detection of endothelial cell-reactive immunoglobulin in patients with anti-phospholipid antibodies. Br J Haematol 79: 595605, 1991
  • 138
    Silver RK, Adler L, Hickman AR, Hageman JR: Anticardiolipin antibody-positive serum enhances endothelial cell plateletactivating factor production. Am J Obset Gynecol 165: 17481752, 1991
  • 139
    Freyssinet JM, Toti-Orfanoudakis F, Ravanat C, Grunebaum L, Gauchy J, Cazenave JP, Wiesel ML: The catalytic role of anionic phospholipids in the activation of protein C by factor Xa and expression of its anticoagulant function in human plasma. Blood Coagul Fibrinolysis 2: 691698, 1991
  • 140
    Joseph J, Scopelitis E: Seronegative antiphospholipid syndrome associated with plasminogen activator inhibitor. Lupus 3: 201203, 1994
  • 141
    Ahmed K, Vianna J, Khamashta M, Hughes G: IL-2, IL-6, and TNF levels in primary antiphospholipid antibody syndrome (letter). Clin Exp Rheumatol 10: 503, 1992
  • 142
    Stricker RB, Davis JA, Gershow J, Yamamoto KS, Kiprov DD: Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus: case report and literature review from the plasmapheresis era. J Rheumatol 19: 14691473, 1992
  • 143
    Cockerell CJ, Lewis JE: Systemic lupus erythematosus-like illness associated with syndrome of abnormally large von Willebrand's factor multimers. South Med J 86: 951953, 1993
  • 144
    Moake JL, Rudy CK, Troll JH, Weinstein MJ, Colannino NM, Azocar J, Seder RH, Hong SL, Deykin D: Unusually large plasma factor VIII: von Willebrand factor multimers in chronic relapsing thrombotic thrombocytopenic purpura. N Engl J Med 303: 14321435, 1982
  • 145
    Takahashi H, Hanano M, Wada K, Tatewaki W, Niwano H, Tsubouchi J, Nakano M, Nakamura T, Shibata A: Circulating thrombomodulin in thrombotic thrombocytopenic purpura. Am J Hematol 38: 174177, 1991
  • 146
    Belmont HM, Levartovsky D, Amin AR, Skovron ML, Buyon J, Giorno R, Rediske J, Abramson SB: Upregulated expression of inducible nitric oxide synthase in SLE: evidence for activated endothelium (abstract). Arthritis Rheum 38 (Suppl 9): S390, 1995
  • 147
    Paulson JC: Selectin/carbohydrate-mediated adhesion of leukocytes. In, Adhesion: Its Role in Inflammatory Disease. Edited by JMHarlan, DYLiu. New York, WH Freeman, 1992